Food, Global Health 3 min

Lyme disease: an innovative vaccine strategy to reduce risks caused by ticks

PRESS RELEASE - Ticks are the number one vector for animal diseases and the number two vector for diseases in humans. The most well-known tick-borne disease, Lyme disease, is caused by a bacterium that cycles between ticks and other animals. An innovative vaccine targeting tick microbiota has been tested to reduce tick susceptibility to infection by the bacteria. The work was carried out by INRAE in partnership with France’s Agency for Food, Environmental and Occupational Health and Safety (ANSES) and the National Veterinary School of Alfort. Findings were published on 24 July in the Microbiome journal.

Published on 24 July 2023

illustration Lyme disease: an innovative vaccine strategy to reduce risks caused by ticks
© Pixabay

Lyme disease is caused the bacteria Borrelia that is carried and transmitted by ticks, notably Ixodes ricinus in Europe and Ixodes scapularis in the United States and Canada. Despite extensive research, as yet there is no vaccine commercially available to prevent the disease. That is why researchers from INRAE, working in partnership with ANSES and the National Veterinary School of Alfort, developed a new kind of vaccine against Lyme disease that works indirectly by targeting ticks.

The idea was to make use of a vaccine that disrupts the tick microbiota.1 For their experiments, researchers injected mice with the vaccine containing a bacteria species found in the tick microbiota.

Once injected, the benign bacteria2 induces the production of antibodies by the mouse. If the mouse is then bitten by a tick, the antibodies interact and modify the tick microbiota, acting as a kind of Trojan horse.

A study of the ticks after feeding on the animal found that those ticks that had bitten vaccinated animals carried much less Borrelia than the ticks that had bitten non-vaccinated animals. The vaccine, when administered to a mouse, “protects” the tick against colonisation by Borrelia, and could also potentially protect the mouse against Lyme disease.

This research led to two important findings: a new understanding of the importance of tick microbiota in Borrelia infection, and a potential strategy for an innovative vaccine. The findings also confirmed that the microbiota is a key element for Borrelia development in ticks. This important data may lead to the development of an innovative vaccine strategy that aims to disrupt the microbiota for the vector of Lyme disease.

1 Borrelia bacteria lives in tick microbiota.

2 A benign strain of Escherichia coli was used for the experiment. While many strains of E. coli exist, only certain strains are harmful.

An issue worldwide
Ticks are not the only vector for diseases. Among others, mosquitos are the vector for a large number of diseases including dengue fever, zika and malaria. Control of these vectors, and protection against them and the diseases they cause, is therefore a major public health issue worldwide. There are no vaccines to protect against any of these diseases; currently available treatments can only alleviate symptoms or provide a cure after infection has occurred. Anti-microbiota vaccines offer an opportunity to develop innovative vaccines against vector-borne diseases.

Wu-Chuang A., Mateos-Hernandez L., Maitre A. et al. (2023). Microbiota perturbation by anti-microbiota vaccine reduces the colonization of Borrelia afzelii in Ixodes ricinus. Microbiome. DOI : 10.1186/s40168-023-01599-7

INRAE Press Office

Scientific contacts

Alejandro CABEZAS-CRUZ Molecular biology and parasitic immunology (BIPAR)



Learn more

Food, Global Health

Tick microbiota and its role in carrying and transmitting pathogens

PRESS RELEASE - Ticks are among the main vectors of pathogens affecting both humans and animals, and thus, pose a serious threat to public and veterinary health. In addition to pathogens, tick microbiota is composed of other microorganisms, with whom they live in symbiosis. Researchers from INRAE and the University of Zaragoza (Spain) conducted a three-year field study to analyse the microbiota of Ixodes Ricinus—a tick vector of the bacteria responsible for Lyme disease—in order to understand its role in the acquisition and transmission of pathogens. Their results, published on 3 July 2021 in Microbiome, show that the structure and composition of tick microbiota evolve over time, and highlight interactions between certain members of the microbiota and pathogens. This study opens up new research opportunities for the development of natural pest control strategies against ticks.

07 July 2021

Food, Global Health

Meteorological maps to help predict tick activity

PRESS RELEASE - As part of the French National plan to combat Lyme disease and other tick-borne diseases, INRAE and VetAgro Sup, together with Anses, Boehringer Ingelheim and CIRAD, have analysed the risks associated with the tick Ixodes ricinus, the main vector of pathogens in France and Europe. For this study, the research team used data collected from seven tick observatories, located in different climates throughout mainland France, as well as meteorological and environmental data (vegetation, soil, etc.). Additional field observation campaigns were also carried out. Their results, published in Geospatial Health and Scientific Reports, have made it possible to develop both a map indicating the most favourable areas for Ixodes ricinus and a model for predicting high-risk periods according to the seasons and weather in France. This first map makes it possible to better assess the risk of human exposure to ticks, and thus, better target prevention campaigns in the different municipalities. In the future, the aim is to combine map and model to produce weather maps capable of predicting the risk of tick bites.

01 June 2022